SEC Form 4 · accession 0001209191-15-074438
Armata Pharmaceuticals, Inc. · ARMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Salka
Officer — Chief Executive Officer · Director
Period of report
Oct 5, 2015
Accepted (ET)
Oct 6, 2015 · 7:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921114
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 5, 2015 | P | 4,200 | $4.75 | A | 4,200 | D |
Table II — derivative securities
No Table II lines on this filing.